Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab + SBRT in locally advanced pancreatic cancer
NCT04098432Phase 2Completed
- Sponsor
- Fakultní nemocnice Hradec Králové
- Start
- Dec 2018
- Primary completion
- Sep 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in pancreatic adenocarcinoma (PDAC), sponsored by Fakultní nemocnice Hradec Králové. Started Dec 2018; status: completed.
02
Drugs
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04098432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04098432.